Saturday, April 27, 2019 12:27:08 PM
CEO has confirmed this via email!
Share structure
Authorized Shares
1,000,000,000
04/15/2019
Outstanding Shares
719,304,721
04/15/2019
Restricted
98,456,186
04/15/2019
Unrestricted
620,848,535
04/15/2019
Held at DTC
588,274,940
04/15/2019
Float
580,235,289
11/12/2018
VDRM has already had increased volume, moved up, and pulled back. This is a perfect opportunity to load before this one becomes current.
Company website
http://www.viadermalicensing.com/
VDRM PRODUCTS SOLD ON AMAZON!
LOS ANGELES, May 29, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is excited to report that since the inaugural sale of VitaStem on Amazon, January 2018, monthly sales continue to increase. In the months of March to April alone, sales increased at a rate of 81% month to month. The newfound success continues as ViaDerma increases its advertising and marketing efforts which include its first commercial ad produced by Brewer Media, a subsidiary of The Brewer Group. ViaDerma Commercial. ViaDerma continues its business development efforts this week with their participation in the upcoming Beauty & Wellness Executive Service Program, hosted by the United States Department of Commerce. ViaDerma President & CEO, Dr. Christopher Otiko will travel to Mumbai, India to attend this groundbreaking event taking place May 30 – June 2, 2018.
The program, hosted by the U.S. Department of Commerce, in partnership with Indian distributors and manufacturers alike has provided an opportunity for U.S. business executives to visit India to obtain a comprehensive overview of the Indian beauty & wellness market and have a series of customized one-on-one meetings with importers, distributors, and partners interested in developing business relationships with U.S. suppliers. This business-oriented program will feature stops in Mumbai and New Delhi. Responsible for organizing this trip on behalf of ViaDerma is The Brewer Group, which is led by long time global impact investor, Ambassador Jack Brewer. The Brewer Group has recently expanded its efforts to manage the ongoing global growth and development of ViaDerma, at a time when ViaDerma is experiencing unmeasured growth.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC:VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, please visit: www.viadermalicensing.com
Contact information:
Investor Relations
Email: info@viadermalicensing.com
Phone: 310-374-6111
https://www.amazon.com/Vitastem-Super-Healing-Antibiotic-Infections-associated/dp/B076V2RM46/ref=sr_1_1?hvadid=153751290665&hvdev=c&hvlocphy=9026782&hvnetw=g&hvpos=1o1&hvqmt=e&hvrand=16667219587410198798&hvtargid=kwd-42550093183&keywords=vitastem&qid=1556379991&s=gateway&sr=8-1
CBD products
https://elixrcannabis.com/
VDRM 52 week range 0.0015-0.01
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM